| Application of C60 fullerene-doxorubicin complex for tumor cell treatment in vitro and in vivo RR Panchuk, SV Prylutska, VV Chumak, NR Skorokhyd, LV Lehka, ... Journal of biomedical nanotechnology 11 (7), 1139-1152, 2015 | 129 | 2015 |
| Mechanisms regulating myoblast fusion: A multilevel interplay L Lehka, MJ Rędowicz Seminars in cell & developmental biology 104, 81-92, 2020 | 106 | 2020 |
| Rapid generation of hydrogen peroxide contributes to the complex cell death induction by the angucycline antibiotic landomycin E RR Panchuk, LV Lehka, A Terenzi, BP Matselyukh, J Rohr, AK Jha, ... Free Radical Biology and Medicine 106, 134-147, 2017 | 34 | 2017 |
| Specific antioxidant compounds differentially modulate cytotoxic activity of doxorubicin and cisplatin: in vitro and in vivo study R Panchuk, N Skorokhyd, V Chumak, L Lehka, S Omelyanchik, ... Croatian medical journal 55 (3), 206-217, 2014 | 30 | 2014 |
| Differential pro-apoptotic effects of synthetic 4-thiazolidinone derivative Les-3288, doxorubicin and temozolomide in human glioma U251 cells LI Коbylinska, OY Klyuchivska, II Grytsyna, N Finiuk, RR Panchuk, ... Croatian medical journal 58 (2), 150, 2017 | 22 | 2017 |
| The role of reactive oxygen species in tumor cells apoptosis induced by landomycin A LV Lehka, RR Panchuk, W Berger, J Rohr, RS Stoika The Ukrainian Biochemical Journal, 72-82, 2015 | 20 | 2015 |
| P2X7 receptor: the regulator of glioma tumor development and survival D Matyśniak, V Chumak, N Nowak, A Kukla, L Lehka, M Oslislok, ... Purinergic Signalling 18 (1), 135-154, 2022 | 16 | 2022 |
| Antioxidants selenomethionine and D-pantethine decrease the negative side effects of doxorubicin in NL/Ly lymphoma-bearing mice RR Panchuk, NR Skorokhyd, Y S Kozak, LV Lehka, VV Chumak, ... Croatian Medical Journal 57 (2), 180-192, 2016 | 16 | 2016 |
| Tissue-protective activity of selenomethionine and D-panthetine in B16 melanoma-bearing mice under doxorubicin treatment is not connected with their ROS scavenging potential RR Panchuk, NR Skorokhyd, YS Kozak, LV Lehka, AG Moiseenok, ... Croatian Medical Journal 58 (2), 171, 2017 | 13 | 2017 |
| Formation of aberrant myotubes by myoblasts lacking myosin VI is associated with alterations in the cytoskeleton organization, myoblast adhesion and fusion L Lehka, M Topolewska, D Wojton, O Karatsai, P Alvarez-Suarez, ... Cells 9 (7), 1673, 2020 | 8 | 2020 |
| Effect of landomycin A on respiration and oxidative phosphorylation in mitochondria V Hreniukh, L Lehka, O Yelisyeyeva, R Panchuk, R Stoika, A Babsky Visnyk of the Lviv University. Series Biology 69, 49-56, 2015 | 8 | 2015 |
| Loss of unconventional myosin VI affects cAMP/PKA signaling in hindlimb skeletal muscle in an age-dependent manner L Lehka, D Wojton, M Topolewska, V Chumak, Ł Majewski, MJ Rędowicz Frontiers in Physiology 13, 933963, 2022 | 6 | 2022 |
| Development of 5-fluorouracil-dichloroacetate mutual prodrugs as anticancer agents E Mironiuk-Puchalska, O Karatsai, A Żuchowska, W Wróblewski, F Borys, ... Bioorganic Chemistry 140, 106784, 2023 | 4 | 2023 |
| Unconventional myosin VI in the heart: involvement in cardiac dysfunction progressing with age O Karatsai, L Lehka, D Wojton, AI Grabowska, MK Duda, R Lenartowski, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1869 (6), 166748, 2023 | 4 | 2023 |
| Impact of N-acetylcysteine on antitumor activity of doxorubicin and landomycin A in NK/Ly lymphoma-bearing mice YS Kozak, RR PaNchUK, NR SKoRoKhYd, LV LehKa, RS StoIKa The Ukrainian Biochemical Journal, 46-54, 2018 | 2 | 2018 |
| Myosin VI in the nucleolus of neurosecretory PC12 cells: its involvement in the maintenance of nucleolar structure and ribosome organization J Nowak, R Lenartowski, K Kalita, L Lehka, O Karatsai, M Lenartowska, ... Frontiers in Physiology 15, 1368416, 2024 | 1 | 2024 |
| Enhancement of anticancer action of traditional (doxorubicin and cisplatin) and experimental (landomycin A) drugs by their delivery in vivo with novel C60-fullerene-based … R Panchuk, S Prylutska, N Skorokhyd, L Lehka, L Skivka, V Hurmach, ... 11th Annual TechConnect World Innovation Conference and Expo, Washington …, 2017 | 1 | 2017 |
| Selenium-containing compounds and D-panthetine modulate the action of doxorubicin and cisplatin towards drug-resistant tumor cells RR Panchuk, NR Skorokhyd, VV Chumak, LV Lehka, AG Moiseenok, ... Біологічні студії/Studia Biologica 7 (3), 33-46, 2013 | 1 | 2013 |
| Search for and identification of molecular targets of angucycline antibiotic landomycin E in human tumor cells RR Panchuk, LV Lehka, BP Matselyukh, RS Stoika Біологічні студії/Studia Biologica 6 (1), 5-18, 2012 | 1 | 2012 |
| Cannabimimetic N-Stearoylethanolamine as “Double-Edged Sword” in Anticancer Chemotherapy: Proapoptotic Effect on Tumor Cells and Suppression of Tumor … R Panchuk, N Skorokhyd, V Chumak, L Lehka, H Kosiakova, T Horid’ko, ... Pharmaceutics 15 (3), 835, 2023 | | 2023 |
